News Brief
World's First Chikungunya Vaccine Gets Green Light From US Drug Regulator
Nayan Dwivedi
Nov 10, 2023, 10:56 AM | Updated 10:56 AM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
In a positive development, US health authorities have granted approval for the world's first chikungunya vaccine, Ixchiq, developed by Europe's Valneva.
The vaccine, aimed at individuals aged 18 and over at an increased risk of exposure, has been identified by the Food and Drug Administration (FDA) as a crucial step in combating the virus, which it labels as "an emerging global health threat", as reported by NDTV.
Chikungunya, transmitted by infected mosquitoes, induces symptoms such as fever and severe joint pain, with the virus predominantly affecting tropical and subtropical regions in Africa, southeast Asia, and parts of the Americas.
The FDA noted the virus's expanding geographical reach, reporting over 5 million cases in the past 15 years.
The vaccine's approval is anticipated to accelerate its deployment in areas with a high prevalence of the disease.
Administered in a single dose, Ixchiq employs a live, weakened version of the chikungunya virus, aligning with the standard approach for vaccine development.
Two clinical trials involving 3,500 participants in North America demonstrated common side effects such as headache, fatigue, muscle and joint pain, fever, and nausea.
While serious reactions were reported in 1.6 per cent of Ixchiq recipients during the trials, with two individuals requiring hospitalization.
The FDA hails this approval as a critical advancement in addressing an unmet medical need for a potentially debilitating disease with limited treatment options.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Nayan Dwivedi is Staff Writer at Swarajya.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.